Sequential analysis of multistage hepatocarcinogenesis reveals that miR-100 and PLK1 dysregulation is an early event maintained along tumor progression

Oncogene

Volumn 31, Issue 42, 2012, Pages 4517-4526

  Petrelli, A ^a   Perra, A ^b   Schernhuber, K ^a   Cargnelutti, M ^a   Salvi, A ^c   Migliore, C ^a   Ghiso, E ^a   Benetti, A ^c   Barlati, S ^c   Ledda Columbano, G M ^b   Portolani, N ^c   De Petro, G ^c   Columbano, A ^b   Giordano, S ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

animal model; HCC; hepatocarcinogenesis; miRNA; PLK1

Indexed keywords

MICRORNA; MICRORNA 100; MICRORNA 99A; POLO LIKE KINASE 1; UNCLASSIFIED DRUG;

ARTICLE; DOWN REGULATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIVER CARCINOGENESIS; LIVER CELL; LIVER CELL CARCINOMA; PRIORITY JOURNAL; TUMOR GROWTH;

ANIMALS; BLOTTING, WESTERN; CARCINOMA, HEPATOCELLULAR; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; DOWN-REGULATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER NEOPLASMS; MICRORNAS; NEOPLASM STAGING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RATS;

ANIMALIA; RATTUS;

EID: 84867742828     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2011.631     Document Type: Article

References (33)

1. Andersen JB, Loi R, Perra A, Factor VM, Ledda-Columbano GM, Columbano A et al. (2010). Progenitor-derived hepatocellular carcinoma model in the rat. Hepatology 51: 1401-1409.
2. Cairo S, Wang Y, de RA, Duroure K, Dahan J, Redon MJ et al. (2010). Stem cell-like micro-RNA signature driven by Myc in aggressive liver cancer. Proc Natl Acad Sci USA 107: 20471-20476.
3. Christodoulou F, Raible F, Tomer R, Simakov O, Trachana K, Klaus S et al. (2010). Ancient animal microRNAs and the evolution of tissue identity. Nature 463: 1084-1088.
4. De Petro G, Tavian D, Copeta A, Portolani N, Giulini SM, Barlati S. (1998). Expression of urokinase-type plasminogen activator (u-PA), u-PA receptor, and tissue-type PA messenger RNAs in human hepatocellular carcinoma. Cancer Res 58: 2234-2239.
5. Eckerdt F, Yuan J, Strebhardt K. (2005). Polo-like kinases and oncogenesis. Oncogene 24: 267-276.
6. Enomoto K, Farber E. (1982). Kinetics of phenotypic maturation of remodeling of hyperplastic nodules during liver carcinogenesis. Cancer Res 42: 2330-2335.
7. Fu L, Medico E. (2007). FLAME, a novel fuzzy clustering method for the analysis of DNA microarray data. BMC Bioinformatics 8: 3.
8. Henson BJ, Bhattacharjee S, O'Dee DM, Feingold E, Gollin SM. (2009). Decreased expression of miR-125b and miR-100 in oral cancer cells contributes to malignancy. Genes Chromosomes Cancer 48: 569-582.
9. Hou J, Lin L, Zhou W, Wang Z, Ding G, Dong Q et al. (2011). Identification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepato-cellular carcinoma. Cancer Cell 19: 232-243.
10. Imbeaud S, Ladeiro Y, Zucman-Rossi J. (2010). Identification of novel oncogenes and tumor suppressors in hepatocellular carcinoma. Semin Liver Dis 30: 75-86.
11. Kota J, Chivukula RR, O'Donnell KA, Wentzel EA, Montgomery CL, Hwang HW et al. (2009). Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell 137: 1005-1017.
12. Ledda-Columbano GM, Curto M, Piga R, Zedda AI, Menegazzi M, Sartori C et al. (1998). In vivo hepatocyte proliferation is inducible through a TNF and IL-6-independent pathway. Oncogene 17: 1039-1044.
13. Lee EJ, Gusev Y, Jiang J, Nuovo GJ, Lerner MR, Frankel WL et al. (2007). Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer 120: 1046-1054.
14. Lee JS, Thorgeirsson SS. (2004). Genome-scale profiling of gene expression in hepatocellular carcinoma: classification, survival prediction, and identification of therapeutic targets. Gastroentero-logy 127: S51-S55.
15. Leite KR, Sousa-Canavez JM, Reis ST, Tomiyama AH, Camara-Lopes LH, Sanudo A et al. (2009). Change in expression of miR-let7c, miR-100, and miR-218 from high grade localized prostate cancer to metastasis. Urol Oncol 29: 265-269.
16. Liu W, Gong YH, Chao TF, Peng XZ, Yuan JG, Ma ZY et al. (2009). Identification of differentially expressed microRNAs by microarray: a possible role for microRNAs gene in medulloblastomas. Chin Med J (Engl) 122: 2405-2411.
17. Lu J, Getz G, Miska EA, varez-Saavedra E, Lamb J, Peck D et al. (2005). MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
18. Nam EJ, Yoon H, Kim SW, Kim H, Kim YT, Kim JH et al. (2008). MicroRNA expression profiles in serous ovarian carcinoma. Clin Cancer Res 14: 2690-2695.
19. Oneyama C, Ikeda J, Okuzaki D, Suzuki K, Kanou T, Shintani Y et al. (2011). MicroRNA-mediated downregulation of mTOR/FGFR3 controls tumor growth induced by Src-related oncogenic pathways. Oncogene 30: 3489-3501.
20. Parkin DM. (2001). Global cancer statistics in the year 2000. Lancet Oncol 2: 533-543.
21. Pellegrino R, Calvisi DF, Ladu S, Ehemann V, Staniscia T, Evert M et al. (2010). Oncogenic and tumor suppressive roles of polo-like kinases in human hepatocellular carcinoma. Hepatology 51: 857-868.
22. Satoh K, Kitahara A, Soma Y, Inaba Y, Hatayama I, Sato K. (1985). Purification, induction, and distribution of placental glutathione transferase: a new marker enzyme for preneoplastic cells in the rat chemical hepatocarcinogenesis. Proc Natl Acad Sci USA 82: 3964-3968.
23. Shi W, Alajez NM, Bastianutto C, Hui AB, Mocanu JD, Ito E et al. (2010). Significance of Plk1 regulation by miR-100 in human nasopharyngeal cancer. Int J Cancer 126: 2036-2048.
24. Smith MR, Wilson ML, Hamanaka R, Chase D, Kung H, Longo DL et al. (1997). Malignant transformation of mammalian cells initiated by constitutive expression of the polo-like kinase. Biochem Biophys Res Commun 234: 397-405.
25. Solt DB, Medline A, Farber E. (1977). Rapid emergence of carcinogen-induced hyperplastic lesions in a new model for the sequential analysis of liver carcinogenesis. Am J Pathol 88: 595-618.
26. Su H, Yang JR, Xu T, Huang J, Xu L, Yuan Y et al. (2009). MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res 69: 1135-1142.
27. Tarantino C, Paolella G, Cozzuto L, Minopoli G, Pastore L, Parisi S et al. (2010). miRNA 34a, 100, and 137 modulate differentiation of mouse embryonic stem cells. FASEB J 24: 3255-3263.
28. Thorgeirsson SS. (2011). The almighty MYC: orchestrating the micro-RNA universe to generate aggressive liver cancer. J Hepatol 55: 486-487.
29. Ueda T, Volinia S, Okumura H, Shimizu M, Taccioli C, Rossi S et al. (2010). Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol 11: 136-146.
30. Varnholt H, Drebber U, Schulze F, Wedemeyer I, Schirmacher P, Dienes HP et al. (2008). MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma. Hepatology 47: 1223-1232.
31. Wang FZ, Weber F, Croce C, Liu CG, Liao X, Pellett PE. (2008). Human cytomegalovirus infection alters expression of cellular microRNA species that affect its replication. J Virol 82: 9065-9074.
32. Wienholds E, Kloosterman WP, Miska E, varez-Saavedra E, Berezikov E, de BE et al. (2005). MicroRNA expression in zebrafish embryonic development. Science 309: 310-311.
33. Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP, Wei WI. (2008). Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res 14: 2588-2592.